Ont. to invest $10M in E. coli vaccine maker
Ontario’s provincial government will make a $10 million investment in Bioniche Life Sciences’ expansion plans for commercial-scale production of its E. coli vaccine for cattle. The company owns the rights to worldwide commercialization of the vaccine, which Bioniche said can prevent E. coli O157:H7 from colonizing in cattle’s digestive systems […]